These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 15919774

  • 1. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.
    Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A.
    Hum Reprod; 2005 Sep; 20(9):2409-13. PubMed ID: 15919774
    [Abstract] [Full Text] [Related]

  • 2. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
    Luque-Ramírez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale HF.
    Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP, Ma RC, Lam PM, Lok IH, Haines CJ, So WY, Tong PC, Cockram CS, Chow CC, Goggins WB.
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [Abstract] [Full Text] [Related]

  • 4. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR, Choi Y, Lee HJ, Oh JY, Hong YS, Sung YA.
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [Abstract] [Full Text] [Related]

  • 5. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA.
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C, Pabuccu R, Berker B, Satiroglu H.
    Fertil Steril; 2010 Mar 01; 93(4):1200-7. PubMed ID: 19131059
    [Abstract] [Full Text] [Related]

  • 9. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women.
    Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, Ku SY, Suh CS, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2008 Aug 01; 23(8):1924-31. PubMed ID: 18579512
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan 01; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
    Erdoğan M, Karadeniz M, Alper GE, Tamsel S, Uluer H, Cağlayan O, Saygili F, Yilmaz C.
    Exp Clin Endocrinol Diabetes; 2008 Mar 01; 116(3):143-7. PubMed ID: 18350479
    [Abstract] [Full Text] [Related]

  • 13. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec 01; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 14. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr 01; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 15. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P.
    Clin Endocrinol (Oxf); 2006 Nov 01; 65(5):655-9. PubMed ID: 17054469
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A.
    Semin Reprod Med; 2008 Jan 01; 26(1):39-44. PubMed ID: 18181081
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
    Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, Janssen OE.
    Exp Clin Endocrinol Diabetes; 2007 Feb 01; 115(2):130-5. PubMed ID: 17318774
    [Abstract] [Full Text] [Related]

  • 18. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.
    Chen MJ, Yang WS, Yang JH, Hsiao CK, Yang YS, Ho HN.
    Hum Reprod; 2006 Sep 01; 21(9):2266-71. PubMed ID: 16757555
    [Abstract] [Full Text] [Related]

  • 19. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E, Campagna AM, Lobo RA.
    Hum Reprod; 2013 Aug 01; 28(8):2245-52. PubMed ID: 23595974
    [Abstract] [Full Text] [Related]

  • 20. Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria.
    Bhattacharya SM.
    J Obstet Gynaecol Res; 2008 Feb 01; 34(1):62-6. PubMed ID: 18226131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.